Journal profile · BIOCHEMISTRY & MOLECULAR BIOLOGY
FEBS Open Bio
ISSN 2211-5463 · Wiley-Blackwell · ENGLAND
FEBS Open Bio: CAS Zone 4 · Biology (2025 upgraded edition); impact factor 2.73; fully open access; APC about USD 2,480; median 115 days to acceptance (86 articles, last 24 months); acceptance rate 32% (journal website); 224 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
FEBS Open Bio is published by Wiley-Blackwell and is in Zone 4 of Biology in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are RNA modifications and cancer, Cancer-related molecular mechanisms research and MicroRNA in disease regulation, together about 24.7% of its articles. Its main subfields are Molecular Biology and Cancer Research. (generated from OpenAlex topic counts and CAS ranking data)
For high-quality, full-length papers and expert reviews relevant to the molecular, cellular and biochemical life sciences.
From the journal's Aims & Scope
Research area (LetPub): BIOCHEMISTRY & MOLECULAR BIOLOGY
Main research topics OpenAlex counts of recent articles; shares are approximate
- RNA modifications and cancerBiochemistry, Genetics and Molecular Biology9.4%
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology7.7%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology7.6%
- RNA Research and SplicingBiochemistry, Genetics and Molecular Biology6.2%
- RNA and protein synthesis mechanismsBiochemistry, Genetics and Molecular Biology5%
- Epigenetics and DNA MethylationBiochemistry, Genetics and Molecular Biology4.4%
- Enzyme Structure and FunctionMaterials Science4.3%
- Autophagy in Disease and TherapyMedicine4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 4 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Biology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 3 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Biology Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 4 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.73LetPub ·
- Impact factor (publisher) 2025
- 2.7Publisher website ·
- CiteScore 2026-06
- 5.1LetPub ·
- CiteScore (publisher) 2025
- 5.1Publisher website ·
- SJR 2026-06
- 0.92LetPub ·
- SNIP 2026-06
- 0.76LetPub ·
- h-index
- 26LetPub ·
- h-index
- 69OpenAlex ·
- i10-index
- 1,214OpenAlex ·
- 2-year mean citedness
- 2.5OpenAlex ·
- Self-citation rate
- 3.7%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 175LetPub ·
- Articles per year (publisher)
- 2Publisher website ·
- Articles per year (publisher) 2025
- 178Publisher website ·
- Downloads per year (publisher) 2025
- 778,684Publisher website ·
Articles by year OpenAlex count · 2,903 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 173 | 173 | 34 |
| 2025 | 224 | 224 | 397 |
| 2024 | 211 | 211 | 1,090 |
| 2023 | 231 | 231 | 1,573 |
| 2022 | 196 | 196 | 1,898 |
| 2021 | 316 | 316 | 4,721 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
115 daysMedian, submission to acceptance · P25–P75 84 days – 165 days
- Acceptance to online
- median 14 days (89 articles)
- Submission to online
- median 134 days
- Sample
- 86 articles with submission and acceptance dates (436 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 10 weeksLetPub ·
- Acceptance rate (publisher) 2025
- 32%Publisher website ·
- Submission to first decision 2025
- 4 daysPublisher website ·
- Submission to acceptance 2025
- 102 daysPublisher website ·
- Acceptance to publication 2025
- 27 daysPublisher website ·
- Submission to publication (journal-reported)
- about 10 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,480 / GBP 1,520 / EUR 1,970 | Yes | CC BY | |
| OpenAlex | USD 2,210 / EUR 1,760 / GBP 1,360 | — | — | |
| LetPub | USD 2,010 / GBP 1,240 / EUR 1,600 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell
- Country or region
- ENGLAND
- Language
- English
- ISSN
- 2211-5463
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about FEBS Open Bio
What CAS zone is FEBS Open Bio in?
In the 2025 upgraded edition of the CAS Journal Ranking, FEBS Open Bio is in Zone 4 of Biology, and in Zone 4 of the minor category Biochemistry & Molecular Biology. In the 2026 Xinrui edition it is in Zone 3 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of FEBS Open Bio?
The latest impact factor listed by LetPub is 2.73; CiteScore 5.1, h-index 69.
How long does peer review take at FEBS Open Bio?
Based on the dates recorded on 86 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 115 days (interquartile range 84–165 days); authors report an average review time of about 10 weeks; the journal's website gives an acceptance rate of 32% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index FEBS Open Bio?
According to LetPub and DOAJ records, FEBS Open Bio is indexed in SCIE, Scopus and DOAJ.
Is FEBS Open Bio open access, and what is the APC?
FEBS Open Bio is a fully open-access journal. APC about USD 2,480.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .